No Data
No Data
Vanda Started at Buy by H.C. Wainwright, Negative Enterprise Value Cited
Street Seen Sleeping on Sleep-Drug Maker Vanda -- Market Talk
Vanda Pharma Analyst Ratings
H.C. Wainwright Initiates Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Announces Target Price $18
Express News | Vanda Pharmaceuticals Inc : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $18
Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024